PROLOR Biotech Inc. (PBTH) Cleared by FDA for US Phase II HGH Trials

08/26/2010 06:15 PM

 

Curaxis Pharmaceutical Corp. (ASCH.OB) Issues Optimistic View and Update on Alzheimer Drug Candidate

08/20/2010 05:36 PM

 

Cryo-Cell International, Inc. (CCEL.OB) Partners with Monash University to Develop Revolutionary Autoimmune Disease Therapies

08/18/2010 04:50 PM

 

Hana Biosciences (HNAB.OB) Posts Q2, Half-Year Financials and Offers Corporate Update

08/16/2010 05:06 PM

 

Radient Pharmaceuticals Corp. (RPC) Appoints Seasoned Director to Head North American Sales

08/13/2010 07:35 PM

 

Helix BioMedix Inc. (HXBM.OB) Posts Record Revenue for Q2 2010

08/09/2010 03:27 PM

 

NewCardio Inc. (NWCI.OB) Achieves Milestone with First Revenue-Generating Technology Study

08/05/2010 03:15 AM

 

CardioGenics (CGNH.OB) Inks “Key Milestone” Commercialization Agreement with Merck-Chimie

08/04/2010 03:27 PM

 

Titan Pharmaceuticals (TTNP.PK) Nears Completion for Phase 3 Study of Opioid Addiction Treatment

08/04/2010 03:01 PM

 

Former U.S. Assistant Surgeon General to Join MusclePharm (MSLP.OB) as Chief Scientific Director

08/03/2010 02:59 PM

 

International Stem Cell Corp. (ISCO.OB) Inks Distribution Agreement with Sristi Biosciences

07/30/2010 07:06 PM

 

Sanguine Corp. (SGUI.OB) Receives Notable Purchase Order from Virginia Commonwealth University

07/28/2010 06:53 PM

 

New Autism Drug Research by Cellceutix on Compound KM-391 Results in Significant Behavioral Changes;

06/14/2010 08:46 PM

New Autism Drug